Management of acute coronary syndrome in patients with chronic kidney disease: If we don't risk anything, we risk even more

Nephron - Clinical Practice

Volumn 119, Issue 4, 2011, Pages

  Asim, Muhammad ^a   Jeffrey, Robin Fraser ^b  

^a HAMAD GENERAL HOSPITAL   (Qatar)

^b BRADFORD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Acute coronary syndrome; Acute kidney injury; Chronic kidney disease; Contrast induced nephropathy

Indexed keywords

IODINATED CONTRAST MEDIUM;

ACUTE CORONARY SYNDROME; ACUTE KIDNEY FAILURE; ARTICLE; CHRONIC KIDNEY DISEASE; DEATH; DIAGNOSTIC TEST; DISEASE SEVERITY; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; KIDNEY DISEASE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL;

ACUTE CORONARY SYNDROME; ACUTE KIDNEY INJURY; ANGIOPLASTY, BALLOON, CORONARY; CHRONIC DISEASE; COMBINED MODALITY THERAPY; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; FIBRINOLYTIC AGENTS; GUIDELINE ADHERENCE; HUMANS; KIDNEY DISEASES; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; TRIIODOBENZOIC ACIDS;

EID: 82955207156     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000331071     Document Type: Article

References (1)

1. McCullough PA, et al: Cardiovascular risk modification in participants with coronary disease screened by the Kidney Early Evaluation Program. Intern Med J 2010; 40: 833-841.